ARCHIVES

Study Tests PARP Inhibitor ABT-888 For Several Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012

Flood Asks ACCC for Greater Community Effort

February 14, 1975

In Brief: Landers Needles Pauling on Vitamin C Study Results; David Goldenberg Heads N.J. Center

October 21, 1983

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

July 2, 1982